Introduction: The inflammatory response to a post-operative infection can increase the risk of tumour recurrence in cancer through the release of pro-inflammatory mediators. The aim of this study was review the literature to assess the relationship between post-operative complications and cancer recurrence. Methods: We performed a literature review of the mechanism of such an association and looked at evidence in different cancer subtypes. Results: A relationship has been identified for many cancer subtypes, and multiple theories have been proposed for the mechanism of this association. Methods to reduce post-operative complications may impact positively on cancer recurrence rates. Conclusion: This review demonstrates that wound complications after surgery can have significant implications for cancer patients. Strategies are required to minimize the risk of post-operative wound complications in patients undergoing cancer resection.

Journal Section:
Review Article
Keywords:
Cancer recurrence, Metastasis, Infection, Complication, Prognosis
1.
NCRI: Cancer Fact Sheets, National Cancer Registry Ireland, 2015.
2.
WHO: Cancer Fact sheet N°297, update. World Health Organization, 2011.
3.
Jemal A, Bray F, Center MM, et al.: Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
4.
O'Leary DP, Wang JH, Cotter TG, Redmond HP: Less stress, more success? Oncological implications of surgery-induced oxidative stress. Gut 2013;62:461-470.
5.
Mangram AJ, Horan TC, Pearson ML, et al.: Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999;27:97-132; quiz 133-134; discussion 196.
6.
Chen J, Gutkin Z, Bawnik J: Postoperative infections in breast surgery. J Hosp Infect 1991;17:61-65.
7.
Cruse PJE, Foord R: The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds. Surg Clin North Am 1980;60:27-40.
8.
Sørensen LT, Hørby J, Friis E, et al.: Smoking as a risk factor for wound healing and infection in breast cancer surgery. Eur J Surg Oncol 2002;28:815-820.
9.
Geerlings SE, Hoepelman AI: Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999;26:259-265.
10.
Holt PG: Immune and inflammatory function in cigarette smokers. Thorax 1987;42:241-249.
11.
Nolan J, Jenkins RA, Kurihara K, Schultz RC: The acute effects of cigarette smoke exposure on experimental skin flaps. Plast Reconstr Surg 1985;75:544-549.
12.
Khansa I, Hendrick RG Jr, Shore A, et al.: Breast reconstruction with tissue expanders: Implementation of a standardized best-practices protocol to reduce infection rates. Plast Reconstr Surg 2014;134:11-18.
13.
Anaya DA, Cormier JN, Xing Y, et al.: Development and validation of a novel stratification tool for identifying cancer patients at increased risk of surgical site infection. Ann Surg 2012;255:134-139.
14.
Olsen MA, Lefta M, Dietz JR, et al.: Risk factors for surgical site infection after major breast operation. J Am Coll Surg 2008;207:326-335.
15.
Mirnezami A, Mirnezami R, Chandrakumaran K, et al.: Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: Systematic review and meta-analysis. Ann Surg 2011;253:890-899.
16.
McSorley ST, Horgan PG, McMillan DC: The impact of the type and severity of postoperative complications on long-term outcomes following surgery for colorectal cancer: A systematic review and meta-analysis. Crit Rev Oncol Hematol 2016;97:168-177.
17.
Krarup PM, Nordholm-Carstensen A, Jorgensen LN, Harling H: Anastomotic leak increases distant recurrence and long-term mortality after curative resection for colonic cancer: A nationwide cohort study. Ann Surg 2014;259:930-938.
18.
Alonso S, Pascual M, Salvans S, et al.: Postoperative intra-abdominal infection and colorectal cancer recurrence: A prospective matched cohort study of inflammatory and angiogenic responses as mechanisms involved in this association. Eur J Surg Oncol 2015;41:208-214.
19.
Laurent C, Sa Cunha A, Couderc P, et al.: Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg 2003;90:1131-1136.
20.
Bohle B, Pera M, Pascual M, et al.: Postoperative intra-abdominal infection increases angiogenesis and tumor recurrence after surgical excision of colon cancer in mice. Surgery 2010;147:120-126.
21.
Salvans S, Mayol X, Alonso S, et al.: Postoperative peritoneal infection enhances migration and invasion capacities of tumor cells in vitro: An insight into the association between anastomotic leak and recurrence after surgery for colorectal cancer. Ann Surg 2014;260:939-943.
22.
Murthy BL, Thomson CS, Dodwell D, et al.: Postoperative wound complications and systemic recurrence in breast cancer. Br J Cancer 2007;97:1211-1217.
23.
Beecher SM, O'Leary DP, McLaughlin R, et al.: Influence of complications following immediate breast reconstruction on breast cancer recurrence rates. Br J Surg 2016;103:391-398.
24.
Yan T, Yin W, Zhou L, et al.: Postoperative fever: The potential relationship with prognosis in node negative breast cancer patients. PLoS One 2010;5:e15903.
25.
Al-Sahaf O, Wang JH, Browne TJ, et al.: Surgical injury enhances the expression of genes that mediate breast cancer metastasis to the lung. Ann Surg 2010;252:1037-1043.
26.
Jackson RM, Rice DH: Wound infections and recurrence in head and neck cancer. Otolaryngol Head Neck Surg 1990;102:331-333.
27.
Rodrigo JP, Suarez C: Prognostic significance of postoperative wound infection on head and neck cancer. Otolaryngol Head Neck Surg 1998;118:272-275.
28.
Ishikawa T, Monden N, Takishita T, et al.: Surgical site infection results in a poor prognosis for oral cancer patients. Jpn J Head Neck Cancer 2013;39:379-384.
29.
Hayashi T, Yoshikawa T, Aoyama T, et al.: Impact of infectious complications on gastric cancer recurrence. Gastric Cancer 2015;18:368-374.
30.
Lerut T, Moons J, Coosemans W, et al.: Postoperative complications after transthoracic esophagectomy for cancer of the esophagus and gastroesophageal junction are correlated with early cancer recurrence: Role of systematic grading of complications using the modified Clavien classification. Ann Surg 2009;250:798-806.
31.
Ohtsuka T, Kitajima Y, Takahashi T, et al.: Infectious complications after gastric cancer surgery accelerate a rapid hepatic recurrence. Hepatogastroenterology 2009;56:1277-1280.
32.
Andalib A, Ramana-Kumar AV, Bartlett G, et al.: Influence of postoperative infectious complications on long-term survival of lung cancer patients: A population-based cohort study. J Thorac Oncol 2013;8:554-561.
33.
Rueth NM, Parsons HM, Habermann EB, et al.: The long-term impact of surgical complications after resection of stage I nonsmall cell lung cancer: A population-based survival analysis. Ann Surg 2011;254:368-374.
34.
Deelman HT: The part played by injury and repair in the development of cancer. Br Med J 1927;1:872-872.
35.
Bodilsen A, Bjerre K, Offersen BV, et al.: The influence of repeat surgery and residual disease on recurrence after breast-conserving surgery: A Danish Breast Cancer Cooperative Group Study. Ann Surg Oncol 2015;22(Suppl 3):S476-485.
36.
Yamaguchi K, Takagi Y, Aoki S, et al.: Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 2000;232:58-65.
37.
Berguer R, Bravo N, Bowyer M, et al.: Major surgery suppresses maximal production of helper T-cell type 1 cytokines without potentiating the release of helper T-cell type 2 cytokines. Arch Surg 1999;134:540-544.
38.
Goldfarb Y, Ben-Eliyahu S: Surgery as a risk factor for breast cancer recurrence and metastasis: Mediating mechanisms and clinical prophylactic approaches. Breast Dis 2006;26:99-114.
39.
Fortner JG: Inadvertent spread of cancer at surgery. J Surg Oncol 1993;53:191-196.
40.
Bogden AE, Moreau JP, Eden PA: Proliferative response of human and animal tumours to surgical wounding of normal tissues: Onset, duration and inhibition. Br J Cancer 1997;75:1021-1027.
41.
Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-1039.
42.
Yu N, Long X, Lujan-Hernandez JR, et al.: Marjolin's ulcer: A preventable malignancy arising from scars. World J Surg Oncol 2013;11:313.
43.
Abramovitch R, Marikovsky M, Meir G, Neeman M: Stimulation of tumour growth by wound-derived growth factors. Br J Cancer 1999;79:1392-1398.
44.
Coussens LM, Werb Z: Inflammation and cancer. Nature 2002;420:860-867.
45.
Pera M, Nelson H, Rajkumar SV, et al.: Influence of postoperative acute-phase response on angiogenesis and tumor growth: Open vs. laparoscopic-assisted surgery in mice. J Gastrointest Surg 2003;7:783-790.
46.
Retsky M, Demicheli R, Hrushesky WJM: Does surgery induce angiogenesis in breast cancer? Indirect evidence from relapse pattern and mammography paradox. Int J Surg 2005;3:179-187.
47.
Cho YA, Sung MK, Yeon JY, et al.: Prognostic role of interleukin-6, interleukin-8, and leptin levels according to breast cancer subtype. Cancer Res Treat 2013;45:210-219.
48.
Baigrie RJ, Lamont PM, Kwaitkowski D, et al.: Systemic cytokine response after major surgery. Br J Surg 1992;79:757-760.
49.
Harmey JH, Bucana CD, Lu W, et al.: Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion. Int J Cancer 2002;101:415-422.
50.
Xue DQ, Qian C, Yang L, Wang XF: Risk factors for surgical site infections after breast surgery: A systematic review and meta-analysis. Eur J Surg Oncol 2012;38:375-381.
51.
Pinsolle V, Grinfeder C, Mathoulin-Pelissier S, Faucher A: Complications analysis of 266 immediate breast reconstructions. J Plast Reconstr Aesthetic Surg 2006;59:1017-1024.
52.
Indelicato D, Grobmyer SR, Newlin H, et al.: Association between operative closure type and acute infection, local recurrence, and disease surveillance in patients undergoing breast conserving therapy for early-stage breast cancer. Surgery 2007;141:645-653.
53.
Bunn F, Jones DJ, Bell-Syer S: Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. Cochrane Database Syst Rev 2012;1:CD005360.
54.
Weber WP, Marti WR, Zwahlen M, et al.: The timing of surgical antimicrobial prophylaxis. Ann Surg 2008;247:918-926.
55.
Ashraf M, Biswas J, Gupta S, Alam N: Determinants of wound infections for breast procedures: Assessment of the risk of wound infection posed by an invasive procedure for subsequent operation. Int J Surg 2009;7:543-546.
56.
Kato H, Nakagami G, Iwahira Y, et al.: Risk factors and risk scoring tool for infection during tissue expansion in tissue expander and implant breast reconstruction. Breast J 2013;19:618-626.
57.
Hogan BV, Peter MB, Achuthan R, et al.: Perioperative reductions in circulating lymphocyte levels predict wound complications after excisional breast cancer surgery. Ann Surg 2011;253:360-364.
58.
Lapsley HM, Vogels R: Quality and cost impacts: Prevention of post-operative clean wound infections. Int J Health Care Qual Assur Inc Leadersh Health Serv 1998;11:222-231.
© 2018 S. Karger GmbH, Freiburg
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2018
You do not currently have access to this content.